Posted in M&A / Deals Lilly to acquire CrossBridge Bio for up to $300m April 15, 2026 Pharmaceutical Technology Eli Lilly and Company has agreed to acquire all outstanding shares of CrossBridge Bio for up to $300m in cash. M&A / DealsRead full story